SurModics (SRDX) Misses Q2 EPS by 4c, provides guidance
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Diluted net income (loss) per common share: 0.21
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Diluted net income (loss) per common share: 0.21
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
SurModics (NASDAQ: SRDX) reported Q2 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $28.1 million versus the consensus estimate of $33.19 million.
GUIDANCE:
SurModics sees FY2025 EPS of ($0.62)-($0.42), versus the consensus of ($0.26). SurModics sees FY2025 revenue of $114-117 million, versus the consensus of $127.3 million.
For earnings history and earnings-related data on SurModics (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
